DELTA Study Dutch evaluation in liver transplantation to assess the efficacy of cyclosporine microemulsion with C2 monitoring versus tacrolimus with trough monitoring in de novo liver transplant recipients

Trial Profile

DELTA Study Dutch evaluation in liver transplantation to assess the efficacy of cyclosporine microemulsion with C2 monitoring versus tacrolimus with trough monitoring in de novo liver transplant recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Ciclosporin (Primary) ; Basiliximab; Methylprednisolone; Prednisone; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms DELTA
  • Sponsors Novartis
  • Most Recent Events

    • 07 Sep 2011 Results presented at the 15th Congress of the European Society for Organ Transplantation.
    • 11 Feb 2011 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
    • 11 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top